Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 602 40 713.3 |
| 96 | EP file number | EAKZ | 10 15 7595.9 |
| 97 | EP publication number | EPN | 2201943 |
| 54 | Designation/title | TI | Neue Verwendung einer Peptidklasse von Verbindungen zur Behandlung von diabetischem neuropathischem Schmerz |
| 51 | IPC main class | ICM
(ICMV) | A61K 31/165 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61P 23/00 (2006.01) |
| 22 | DE application date | DAT | Mar 19, 2002 |
| 96 | EP application date | EAT | Mar 19, 2002 |
| 43 | Date of first publication | OT | Jun 30, 2010 |
| Date of publication of grant | PET | Aug 3, 2011 |
| 71/73 | Applicant/owner | INH | UCB Pharma GmbH, 40789 Monheim, DE |
| 72 | Inventor | IN | Selve, Norma, 53842 Troisdorf, DE |
| Address for service | | UCB Pharma GmbH, 40789 Monheim, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| EP
01107026
Mar 21, 2001
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002201943
Searchable text:
EP000002201943
Original document:
EP000002201943B1
Searchable text:
EP000002201943B1 |
| 43 | Date of first publication | EVT | Jun 30, 2010 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 7, 2020
(Show all update days)(Hide all update days)- Jan 7, 2020; May 29, 2015; Jan 15, 2015; Nov 18, 2014; Jul 22, 2014; Jul 16, 2014; Apr 9, 2014; Apr 10, 2013; Mar 28, 2013; Feb 14, 2013; Aug 30, 2012; May 1, 2012; Apr 7, 2012; Sep 29, 2011; Sep 15, 2011; Aug 12, 2011; Aug 5, 2011; Jul 27, 2011
- Historical data not available for this/these date(s)
- May 26, 2011
- Date of the first transfer into DPMAregister
|
